Advisor Group Holdings, Inc. Cti Biopharma Corp Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.2 - $6.01 $420 - $601	100 Added 9.79%	1,121 $4,000
Q4 2022 Feb 10, 2023	BUY	$4.45 - $6.17 $4,450 - $6,170	1,000 Added 4761.9%	1,021 $6,000
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $5 - $7	-1 Reduced 4.55%	21 $0
Q2 2022 Aug 10, 2022	SELL	$3.55 - $6.27 $37,725 - $66,631	-10,627 Reduced 99.79%	22 $0
Q1 2022 May 04, 2022	SELL	$1.9 - $5.23 $950 - $2,615	-500 Reduced 4.48%	10,649 $50,000

Q3 2021 Nov 05, 2021	BUY	$2.25 - $3.18 $1,053 - $1,488	468 Added 4.38%	11,149 $32,000
Q1 2021 May 13, 2021	BUY	$2.68 - $3.8 $26,473 - $37,536	9,878 Added 1230.14%	10,681 $31,000
Q2 2020 Aug 14, 2020	SELL	$0.88 - $1.32 $299 - $448	-340 Reduced 29.75%	803 $1,000
Q1 2020 May 18, 2020	BUY	$0.69 - $1.54 $788 - $1,760	1,143 New	1,143 $1,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.